A comprehensive view of Johns Hopkins University. This page highlights a small sample of our full coverage.
For real-time access, please log in to your R&D/Patents Market Intelligence Service.
Johns Hopkins University explores advancements in food allergy treatment, including first approved therapy for peanut allergy, alternative routes of delivery, and use of modified allergens
Published:
May 02, 2024
by Immunotherapy Daily
|
Naturally occurring chemical found in cannabis could lessen the anxiety-inducing effects of THC; findings could advance medicinal use of THC, according to Johns Hopkins Medicine-led research
Published:
April 11, 2024
by States News Service
|
Merck requests the US Patent and Trademark Office to intervene in Keytruda-related patents dispute with Johns Hopkins University; Merck alleges the four patents were based on collaborative research but filed without their notification or involvement
Published:
March 14, 2024
by FiercePharma
|
Flavored nicotine pouches such as the brand Zyn grow in popularity among young people, prompting Johns Hopkins University researchers to examine their potential allure for students due to the products' discrete nature
Published:
March 12, 2024
by ENP Newswire
|
Johns Hopkins Medicine study finds home-use rapid antigen test accurately detects SARS-CoV-2; test compares favorably with clinician-administered test, offering key data on self-testing during the pandemic
Published:
February 13, 2024
by States News Service
|
Ask us about our R&D/Patents market view